Ultralife Corporation
ULBI
$7.44
$0.223.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.05% | -2.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.05% | -2.14% | |||
| Cost of Revenue | -8.73% | 2.50% | |||
| Gross Profit | 37.15% | -16.14% | |||
| SG&A Expenses | -3.02% | 0.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.82% | 2.40% | |||
| Operating Income | 583.70% | -77.13% | |||
| Income Before Tax | 550.38% | 93.50% | |||
| Income Tax Expenses | 343.75% | 93.03% | |||
| Earnings from Continuing Operations | 634.61% | 93.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 25.00% | -35.48% | |||
| Net Income | 663.86% | 93.92% | |||
| EBIT | 583.70% | -77.13% | |||
| EBITDA | 189.04% | -52.01% | |||
| EPS Basic | 663.47% | 93.92% | |||
| Normalized Basic EPS | 1,711.11% | -93.28% | |||
| EPS Diluted | 600.00% | 93.27% | |||
| Normalized Diluted EPS | 1,704.94% | -93.28% | |||
| Average Basic Shares Outstanding | 0.01% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||